Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study

Shuhei Hara(Jikei University School of Medicine), Taro Igarashi(Jikei University School of Medicine), Hiroki Yamada(Keio University), Shoji Kimura(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Wataru Fukuokaya(Jikei University School of Medicine), Jun Miki(Jikei University School of Medicine), Keiichiro Mori(Jikei University School of Medicine), Masaya Murakami(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Kojiro Tashiro(Jikei University School of Medicine), Takashi Ohtsuka(Keio University), Shunsuke Tsuzuki(Jikei University School of Medicine), Yu Imai(Jikei University School of Medicine), Akira Furuta(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Koichi Aikawa(Jikei University School of Medicine), Mahito Atsuta(Jikei University Kashiwa hospital), Brendan A. Yanada(Jikei University School of Medicine), Yuya Iwamoto(Jikei University School of Medicine), Kenichi Hata(Jikei University School of Medicine), Yuma Goto(Jikei University School of Medicine)
Japanese Journal of Clinical Oncology
October 19, 2024
Cited by 4


Related Papers